Document Detail


Prevalence of hepatitis E virus infection in liver transplant recipients.
MedLine Citation:
PMID:  19790147     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatitis E virus (HEV) infection is known to run a self-limited course. Recently, chronic hepatitis E has been described in several immunosuppressed patients after solid organ transplantation. The prevalence of HEV infection after transplantation, however, is unknown. We studied HEV parameters [HEV RNA, HEV immunoglobulin M (IgM), and HEV immunoglobulin G (IgG) by enzyme-linked immunosorbent assay and confirmatory immunoblotting] in a cohort of 285 adult liver transplant recipients. The most recent freeze-stored sera were investigated, and if they were positive, a retrospective analysis was performed. Samples from 274 patients (96.1%) tested negative for all HEV parameters. This included a patient described earlier as having experienced an episode of chronic HEV hepatitis in the past. One patient was found positive for HEV RNA without HEV antibodies. She presently suffers from chronic HEV hepatitis and has also been described before. Sera from 9 patients tested positive for HEV IgG without HEV IgM or HEV RNA. Six of these 9 patients (2.1% of the total) were found to have HEV IgG antibodies in retrospect related to an HEV infection at some time pre-transplant as they also tested positive in a pretransplant serum sample. One of these 9 patients suffered in retrospect from a chronic HEV infection with mild hepatitis between 2 and 5 years after liver transplantation on the basis of the course of HEV RNA, IgM, and IgG, aminotransferases, and liver histology. Overall, the prevalence of acquired HEV hepatitis after liver transplantation was 1% in this cohort. We conclude that liver transplant recipients have a risk for chronic HEV infection, but the prevalence is low.
Authors:
Elizabeth B Haagsma; Hubert G M Niesters; Arie P van den Berg; Annelies Riezebos-Brilman; Robert J Porte; Harry Vennema; Johan H J Reimerink; Marion P G Koopmans
Related Documents :
12395337 - A pilot study of interferon alfa and ribavirin combination in liver transplant recipien...
9157927 - Incidence and treatment of recurrent hepatitis c after liver transplantation.
9279207 - Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related...
8578227 - Hepatitis b-associated liver cirrhosis as an indication for liver transplantation.
18225767 - Serotonin is involved in the regulation of histogenetic processes in rat embryonic neoc...
7150907 - An experimental study of the anatomy of the tubules of the human kidney and its relatio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society     Volume:  15     ISSN:  1527-6473     ISO Abbreviation:  Liver Transpl.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-05     Completed Date:  2009-12-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100909185     Medline TA:  Liver Transpl     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1225-8     Citation Subset:  IM    
Copyright Information:
Copyright 2009 AASLD
Affiliation:
Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. e.b.haagsma@int.umcg.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cohort Studies
Enzyme-Linked Immunosorbent Assay / methods
Female
Hepatitis E / complications*,  epidemiology*,  virology
Hepatitis E virus / metabolism*
Humans
Immunoglobulin G / metabolism
Immunoglobulin M / metabolism
Liver Diseases / complications*,  epidemiology*,  virology
Liver Transplantation / methods*
Male
Middle Aged
Prevalence
RNA, Viral / metabolism
Retrospective Studies
Risk
Chemical
Reg. No./Substance:
0/Immunoglobulin G; 0/Immunoglobulin M; 0/RNA, Viral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected pat...
Next Document:  Acute liver failure at 26 weeks' gestation in a patient with sickle cell disease.